https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14865 Tue 13 Aug 2024 08:51:00 AEST ]]> Association of pembrolizumab with tumor response and survival among patients with advanced melanoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29369 Sat 24 Mar 2018 07:34:17 AEDT ]]>